Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 158

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

VEGI, a novel cytokine of the tumor necrosis factor family, is an angiogenesis inhibitor that suppresses the growth of colon carcinomas in vivo

ZHAI, YIFAN, NI, JIAN, JIANG, GONG‐Wei, LU, JIAMO, XING, LILY, LINCOLN, CLINT, CARTER, KENNETH C., JANAT, FOUAD, KOZAK, DIANE, XU, SIMIN, ROJAS, LORENA, AGGARWAL, BHARAT B., RUBEN, STEVE, LI, LU‐YUAN, GENTZ, REINER, YU, GUO‐LIANG · 1999 · The FASEB Journal

Abstract

A novel member of the tumor necrosis factor (TNF) family has been identified from the human umbilical vein endothelial cell cDNA library, named vascular endothelial growth inhibitor (VEGI). The VEGI gene was mapped to human chromosome 9q32. The cDNA for VEGI encodes a protein of 174 amino acid residues with the characteristics of a type II transmembrane protein. Its amino acid sequence is 20–30% identical to other members of the TNF family. Unlike other members of the TNF family, VEGI is expressed predominantly in endothelial cells. Local production of a secreted form of VEGI via gene transfer caused complete suppression of the growth of MC‐38 murine colon cancers in syngeneic C57BL/6 mice. Histological examination showed marked reduction of vascularization in MC‐38 tumors that expressed soluble but not membrane‐bound VEGI or were transfected with control vector. The conditioned media from soluble VEGI‐expressing cells showed marked inhibitory effect on in vitro proliferation of adult bovine aortic endothelial cells. Our data suggest that VEGI is a novel angiogenesis inhibitor of the TNF family and functions in part by directly inhibiting endothelial cell proliferation. The results further suggest that VEGI maybe highly valuable toward angiogenesis‐based cancer therapy.—Zhai, Y., Ni, J., Jiang, G.‐W., Lu, J., Xing, L., Lincoln, C., Carter, K. C., Janat, F., Kozak, D., Xu, S., Rojas, L., Aggarwal, B. B., Ruben, S., Li, L.‐Y., Gentz, R., Yu, G.‐L. VEGI, a novel cytokine of the tumor necrosis factor family, is an angiogenesis inhibitor that suppresses the growth of colon carcinomas in vivo . FASEB J. 13, 181‐189 (1999)

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1096/fasebj.13.1.181

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 158

Metadata

Authors
ZHAI, Y., NI, J., JIANG, G., LU, J., XING, L., LINCOLN, C., CARTER, K. C., JANAT, F., KOZAK, D., XU, S., ROJAS, L., AGGARWAL, B. B., RUBEN, S., LI, L., GENTZ, R., & YU, G.
Venue
The FASEB Journal
Publisher
Wiley
Published
1999-01
Volume
13
Issue
1
Pages
181-189
ISSN
  • 0892-6638 (ISSN-L)
  • 1530-6860
OpenAlex
W1874909451
Cited by
158
References
3
FWCI
3.15
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: VEGI, a novel cytokine of the tumor necrosis factor family, is an angiogenesis inhibitor that suppresses the growth of colon carcinomas in vivo. https://app.cochat.ai/papers/10.1096/fasebj.13.1.181
The paper
ZHAI, Y., NI, J., JIANG, G., LU, J., XING, L., LINCOLN, C., CARTER, K. C., JANAT, F., KOZAK, D., XU, S., ROJAS, L., AGGARWAL, B. B., RUBEN, S., LI, L., GENTZ, R., & YU, G. (1999). VEGI, a novel cytokine of the tumor necrosis factor family, is an angiogenesis inhibitor that suppresses the growth of colon carcinomas in vivo. The FASEB Journal. https://doi.org/10.1096/fasebj.13.1.181

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.